Newsroom

        

Q atar Foundation established Qatar National Research Fund (QNRF) in 2006 as part of its ongoing commitment to establish Qatar as a knowledge-based economy. Qatar Foundation views research as essential to national and regional growth; as the means to diversify the nation’s economy, enhance educational offerings and develop areas that affect the community, such as health and environment. 

Qatar National Research Fund aims to foster original, competitively selected research in More...


 

  • Time Zone: Arabia Time Zone UTC+03:00
  • Address: PO Box 5825, Doha, Qatar



أنشأت مؤسسة قطر الصندوق القطري لرعاية البحث العلمي عام 2006 كجزء من التزامها المستمر بإقامة الاقتصاد القائم على المعرفة في دولة قطر. وتولي مؤسسة قطر للبحوث أهمية قصوى استنادًا إلى دورها الحيوي في تحقيق النمو سواء داخل قطر أو على الصعيد الإقليمي، وكونها وسيلة لتنويع اقتصاد البلاد، وتعزيز الفرص التعليمية، وتطوير المجالات المؤثرة في المجتمع كالصحة والبيئة.

ويهدف الصندوق القطري لرعاية البحث العلمي إلى تشجيع الأبحاث المبتكرة المختارة على أساس تنافسي في

المزيد ...


  • التوقيت: توقيت غرينتش +3
  • صندوق البريد: 5825 الدوحة, قطر
  • فاكس: 8079 4454 974
  • الدعم الفني: support.qnrf.org
  • الموقع الالكتروني: www.qnrf.org

Saturday, December 9, 2023 4:43 AM Doha Time

Research Outcome Seminar (ROS)
QNRF PR
/ Categories: Announcements

Research Outcome Seminar (ROS)

Advancing Research in Pediatric Diseases and Conditions

The scope and pace of pediatric research discoveries are rooted in our understanding of basic science through to clinical studies, as well as improved technologies, which have advanced disease outcomes in children. Greater advocacy, governance and the imperative to conduct collaborative pediatric clinical trials, have also accelerated change in clinical policies and public health practices.

Emerging competitive programs and research priorities at QNRF will continue to build new knowledge critical to child health. For example, the support of genomic approaches and regenerative medicine, has led their rapid integration into the diagnosis of hereditary diseases in children. QNRF’s support of pediatric interventions, recognises that such treatments in adulthood may have limited success.

To learn more about this, you are invited to an online seminar which will highlight QNRF’s commitment and continual investment in supporting a broad-based biomedical research in understanding the hereditary and developmental origins of pediatric diseases and conditions in Qatar.

The seminar will feature presentations delivered by selected QNRF-funded researchers, who will share the details of their projects in line with Qatar’s National Research Priorities, followed by a panel discussion. More importantly, the ROS will also provide attendees with an opportunity to network, collaborate and share the benefits of their work with other researchers and the public.

  • Time:        10:00 AM – 12:30 PM (Doha Time)
  • Date:         Sunday, 26 September 2021
  • Venue:      Online Webinar

You can join the seminar directly by clicking here.

We look forward to your attendance.

Program Schedule

 

Time

Topic

Presenter

10:00-10.15

Welcome and QNRF’s Portfolio in Pediatric Research

Dr. Fatemeh Darakhshan-Rassam

Program Manager, Biomedical Science & Health, QNRF                                     

10:15 – 10:25   

Keynote Speech

Dr. Barbro Fridén

Chief Executive Officer, Sidra Medicine

Presentations of the Projects

10:25 – 10:40    

Understanding the epidemiology, prevalence and genetic mechanisms of diabetes mellitus in children in the State of Qatar

Project Number: NPRP10-0206-170370

Prof. Khalid Hussain,

Chief of Endocrinology, Sidra Medicine

Professor of Pediatrics, WCM-Q

10:40 – 10:55         

Towards a systems-level understanding of pediatric Inflammatory Bowel Disease in Qatar: interplay between the immunogenome and the microbiome

Project Number: NPRP10-0125-170242

Dr. Souhaila Al Khodor

Director of Maternal and Child Health Program, Sidra Medicine

10:55 – 11:10

Microenvironmental targets for restoring anti-tumor immunity in childhood acute leukemias

Project Number: NPRP8-2297-3-494

Dr. Chiara Cugno

Director of Advanced Cell Therapy Core, Attending Physician Pediatric Hem-Onc, Sidra Medicine

11:10 – 11:25

Building haplotype-resolved denovo genome maps for Qatari family trios with severe developmental disorders as a premium resource to enhance diagnosis & uncover their etiology in the Qatari population                                                                     

Project Number: NPRP10-1219-160035

Dr. Younes Mokrab

Principal Investigator in Translational Genetics and Bioinformatics, Sidra Medicine

11:25 – 11:40

PhD - Genotype-Phenotype Correlation in Stargardt Disease

Project Number: GSRA6-1-0329-19010

Dr. Saoud Al-Khuzaei

PhD Student,

Oxford University

11:40 – 11:50

Q & A Session

Panel Discussion and Closing Remarks

11:50 – 12:30

Prof. Ibrahim AL-Janahi

Professor of Clinical Pediatrics, WCM-Q

Chairman and DIO, Department of Pediatric Medicine, Sidra Medicine

Dr. Khalid Fakhro

Chief Research Officer and Director of Precision Medicine Program,

Sidra Medicine

Dr. Ahsan Nazeer

Division Chief, Child and Adolescent Psychiatry, Sidra Medicine

Associate Professor, Clinical Psychiatry, WCM-Q
 

 

Previous Article GSRA8+: Graduate Sponsorship Research Award International Track Special Call
Next Article Launch of the 3rd Cycle of the Food Security Call
Print
6699
«December 2023»
SunMonTueWedThuFriSat
262728293012
3456789
10111213141516
17181920212223
24252627282930
31123456

Archive